Compare CNTN & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTN | SPCE |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.2M | 175.5M |
| IPO Year | 2022 | 2017 |
| Metric | CNTN | SPCE |
|---|---|---|
| Price | $3.28 | $2.97 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.26 |
| AVG Volume (30 Days) | 429.9K | ★ 5.6M |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,544,000.00 |
| Revenue This Year | N/A | $2,766.13 |
| Revenue Next Year | N/A | $699.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.02 | $2.13 |
| 52 Week High | $5.27 | $5.59 |
| Indicator | CNTN | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 65.58 |
| Support Level | $3.11 | $2.91 |
| Resistance Level | $3.51 | $3.42 |
| Average True Range (ATR) | 0.24 | 0.24 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 49.00 | 72.26 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.